Compounded Options While branded GLP-1 agonists like Ozempic and Wegovy are effective, they can be costly
A phase 2 trial has begun for ASC30 in its oral form to treat diabetes, and the drug demonstrated a 5.4%, 7%, and 7.7% decline in weight in participants who were given 20 mg, 40 mg, and 60 mg doses of the drug, respectively, in 13 weeks
Are cold breakfasts better on GLP-1
Originally identified in human plasma, this naturally occurring molecule has become one of the most extensively investigated compounds in regenerative biology research
Crossref Zakhour J, Ayoubi LWE, Kanj SS
Cardiovascular Outcomes : Treatments that offer cardiovascular benefits are increasingly preferred in T2D management due to the high risk of cardiovascular disease in this population